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Abstract
Background: Protein over-production in Escherichia coli often results in formation of inclusion bodies (IBs). Some
recent reports have shown that the aggregation into IBs does not necessarily mean that the target protein is
inactivated and that IBs may contain a high proportion of correctly folded protein. This proportion is variable
depending on the protein itself, the genetic background of the producing cells and the expression temperature. In
this paper we have evaluated the influence of other production process parameters on the quality of an inclusion
bodies protein.
Results: The present paper describes the recombinant production in Escherichia coli of the flavohemoglobin from
the Antarctic bacterium Pseudoalteromonas haloplanktis TAC125. Flavohemoglobins are multidomain proteins
requiring FAD and heme cofactors. The production was carried out in several different experimental setups
differing in bioreactor geometry, oxygen supply and the presence of a nitrosating compound. In all production
processes, the recombinant protein accumulates in IBs, from which it was solubilized in non-denaturing conditions.
Comparing structural properties of the solubilized flavohemoglobins, i.e. deriving from the different process
designs, our data demonstrated that the protein preparations differ significantly in the presence of cofactors (heme
and FAD) and as far as their secondary and tertiary structure content is concerned.
Conclusions: Data reported in this paper demonstrate that other production process parameters, besides growth
temperature, can influence the structure of a recombinant product that accumulates in IBs. To the best of our
knowledge, this is the first reported example in which the structural properties of a protein solubilized from
inclusion bodies have been correlated to the production process design.
Background
Protein over-production in Escherichia coli (E. coli)
often results in formation of inclusion bodies (IBs).
Aggregation most probably occurs as a consequence of
interactions among the newly-formed folding intermedi-
ates which expose hydrophobic residues at their surface
[1]. For a long time it was believed that IBs were com-
pact, insoluble aggregates of misfolded proteins [2],
remaining in the cell as biologically inactive deposits.
However, some recent reports have shown that the
aggregation into IBs does not necessarily mean that
the target protein is inactivated [3,4]. Structural data
collected from many model proteins revealed the pre-
sence of significant proportions of native-like second-
ary structure in IBs proteins [5,6]. Consequently, it is
not surprising that the analysis of the biological prop-
erties of IBs formed by enzymes demonstrated in some
cases the occurrence of enzym a t i ca c t i v i t yi n s i d et h e
IBs [3,7]. These evidences introduced the concept that
IBs are composed, at least partially, by functional poly-
peptides, whose deposition is necessarily driven by dis-
crete aggregation determinants, that act irrespective of
the global folding state of the protein [8]. It has been
observed that IBs containing a high proportion of cor-
rectly folded protein can be easily solubilized under
non-denaturing conditions [9] by using mild detergents
or polar solvents, widely preserving the target protein
folding.
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logical activity of IB proteins is variable depending on
t h ep r o t e i ni t s e l f ,t h eg e n e t i cb a c k g r o u n do ft h ep r o d u -
cing cells and the expression temperature [6,10].
Flavohemoglobins (flavoHbs) have been identified in a
number of bacteria and yeasts [11]. These proteins are
characterized by a modular structure, where a N-term-
inal hemoglobin domain, displaying a classical three-
over-three a-helical sandwich motif around a single
heme b [12], is linked to a C-terminal FAD-containing
reductase domain which resembles ferredoxin reductase
[13]. The flavoHbs C-terminal domain binds NAD(P)H
and transfers electrons to the heme in the globin
domain via FAD [14,15].
It is generally believed that flavohemoglobins provide
protection against NO and related reactive nitrogen spe-
cies although the exact mechanism of action is still
under debate [16-21].
A flavoHb encoding gene (PSHAa2880) was identified
by in silico genome analysis of the Antarctic Gram-
negative marine eubacterium Pseudoalteromonas halo-
planktis TAC125 (P. haloplanktis TAC125) [22]. In the
present paper, the recombinant production of the psy-
chrophilic flavoHb (hereinafter called PhflavoHb) in E.
coli cells was carried out in several different experimen-
tal setups in order to identify the best production condi-
tion. Indeed, previously reported results on E. coli
flavoHb demonstrated that the heterologous over-pro-
duction of flavoHb may lead to host cell damage due to
the action of flavoHb as a potent generator of products
of oxygen radical partial reduction (i.e., superoxide and
peroxide) [23-25]. Due to the expected toxicity of the
recombinant product, flavoHb recombinant productions
were carried out exploring several expression systems
and/or microbial cell factories, with different results
[26]. Amongst many other examples reported in litera-
ture, recombinant production of E. coli flavoHb in E.
coli was obtained in absence of oxygen and in presence
of nitrosating compound, an experimental setup in
which the hmp gene expression is physiologic and the
flavoHb activity is required [27].
Starting from the above information, in the present
work, the recombinant production of the flavoHb from
the Antarctic Gram-negative bacterium P. haloplanktis
TAC125 [22] was performed in E. coli cells exploring
some conditions differing in presence of a nitrosating
compound and in O2 supply.
All production processes resulted in the accumulation
of the recombinant protein in IBs, from which it was
solubilized in non-denaturing conditions. Comparing
structural properties of the solubilized PhflavoHbs, i.e.
deriving from the different production processes, our
data demonstrated that the protein preparations differ
significantly in the presence of cofactors (heme and
FAD) and in their secondary and tertiary structure,
demonstrating the impact of the specific production
process design on the quality of inclusion bodies
protein.
Results
Recombinant production of P. haloplanktis TAC125
flavohemoglobin in E. coli cells resulted in full deposition
of the protein in the inclusion bodies
The PSHAa2880 gene was PCR amplified to suitably
introduce NdeI and SalI restriction sites, and cloned
into pET22b vector corresponding sites, thus generating
the recombinant pET22b-2880 plasmid.
E. coli BL21(DE3) cells were transformed with the
recombinant vector and, keeping in mind that proteins
coming from psychrophilic micro-organisms are often
characterized by a moderate to extreme thermal-lability
[28], the production of the PhflavoHb was carried out at
20°C. However, two different production process setups
were explored. First, E. coli BL21(DE3)(pET22b-2880)
recombinant cells were grown in a 7.5 L automatic fer-
menter, in which the recombinant mesophilic cells were
grown aerobically at 20°C till the culture density reached
the value of 0.6 OD at 600 nm. Induction was then per-
formed by IPTG, in the following conditions: i) addition
of heme and FAD precursors (i.e. D-aminolevulinic acid,
FeCl3, and riboflavin); ii) addition of the nitrosating
compound sodium nitroprusside (SNP), and iii) in
microaerophilic conditions (dissolved oxygen tension
always below 5% of saturation). Microareophilic condi-
tions were achieved by stopping air supply during the
next 16-18 hr of fermentation. The second experimental
condition consisted in growing recombinant cells in
shake flask at 20°C until the culture absorbance at 600
n mr e a c h e d0 . 6O D ,w h e nt h ep r o t e i np r o d u c t i o nw a s
induced in the same conditions as in automatic fermen-
ter but without SNP and in aerobic conditions.
Then, cells coming from the above production pro-
cesses were analyzed looking for production and solu-
ble/insoluble distribution of the recombinant protein by
cell fractionation followed by SDS-PAGE analysis. Both
production processes resulted in the total deposition of
recombinant flavohemoglobin as cytosolic inclusion
bodies (IBs), that were called flask-flavoHb IBs and
ferm-flavoHb IBs if derived from cells grown in shake
flasks or in fermenter, respectively.
Recombinant P. haloplanktis TAC125 flavohemoglobin is
solubilized from inclusion bodies by non-denaturing
solutions
Treatment of P. haloplanktis TAC125 flavo-Hb IBs with
different non-denaturing solvents such as low concen-
tration of mild detergents or polar solvents was applied
to the recovery of the recombinant protein in solution.
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Page 2 of 10Identical aliquots of flask-flavoHb IBs and ferm-flavoHb
IBs were incubated overnight at 4°C with different non-
denaturing solutions (i.e. buffered solutions containing
0.2% N-lauroyl sarcosine, or 5% DMSO, or 5% n-propa-
nol, or 0.5% Triton X-100, or 1% Na-deoxycholate).
Solubilized proteins were then separated from the inso-
luble matter by a centrifugation step and subjected to
SDS-PAGE analysis. As shown in figure 1, both ferm-
flavoHb IBs (panel A) and flask-flavoHb IBs (panel B)
are partially solubilized in all tested conditions, although
the solubilization yields (defined as the percentage of
solubilized proteins relative to the total amount con-
tained into the IBs sample) result to be quite different
(Table 1). Indeed, best recovery in solution was obtained
in N-lauroyl sarcosine either for ferm-flavoHb IBs or
flask-flavoHb IBs (Table 1), but the corresponding
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Figure 1 Solubilization of flavoHb inclusion bodies produced in automatic fermenter (panel A) and shake flask (panel B).S a m e
amounts of IBs were re-suspended in 40 mM Tris/HCl, pH 8.0 buffer containing different non denaturing agents. Same volumes of solubilized
proteins were analysed by SDS-PAGE. Black star indicates that the loaded sample corresponds to one tenth of the other samples.
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Page 3 of 10solubilization yields exceed 95% in case of ferm-flavoHb
IBs, while only about fifty percent of total proteins con-
tained into IBs from flask culture went in solution. It is
worth mentioning that in figure 1 the loaded amount of
N-lauroyl sarcosine solubilized samples correspond to
one tenth of the other samples.
The two solubilized IBs preparations also differ in
their respective protein composition. As shown in figure
1, flask-flavoHb IBs seems to contain several proteins
other than flavoHb (panel B), while IBs produced in fer-
menter contains almost only the psychrophilic recombi-
nant protein (panel A).
Structural comparison of recombinant P. haloplanktis
TAC125 ferm- and flask-flavoHb
Flavohemoglobins extracted from either flask-flavoHb
IBs (flask-flavoHb) or ferm-flavoHb IBs (ferm-flavoHb)
were subjected to further analyses to investigate the
presence of the two protein cofactors, i.e. heme and
FAD.
Absorption spectra of heme-containing proteins are
characterized by the presence of Soret signal, a peak
centred at about 413 nm. Therefore, UV/VIS absorption
spectra of each solubilized flavoHb were recorded, and
their respective spectra regions between 380 and 450
nm are shown in figure 2. Only the ferm-flavoHb spec-
trum is characterized by the presence of a typical Soret
signal, centred at about 413 nm (Figure 2).
Then, the presence of the FAD cofactor in flask-fla-
voHb and ferm-flavoHb proteins was investigated by
fluorescence measurements. In detail, emission spectra
between 500 nm and 600 nm, exciting at 450 nm, were
recorded and are shown in figure 3. An emission signal
at 520 nm, which is indicative of the presence of the
FAD cofactor, was only detected in the ferm-flavoHb
fluorescence spectrum (Figure 3).
Table 1 Percentage of solubilization of IBs in different
solvents
% solubilized protein
Solubilization solution ferm-flavoHb flask-flavoHb
0.5% Triton X-100 in 40 mM
Tris/HCl, pH 8.0
8 ± 0.6 10 ± 0.9
5% DMSO in 40 mM Tris/HCl, pH 8.0 9 ± 0.9 5 ± 0.4
5% di n-propanol in 40 mM
Tris/HCl, pH 8.0
6 ± 0.7 5 ± 0.1
0.2% N-lauroyl sarcosine in 40 mM
Tris/HCl, pH 8.0
95 ± 1.0 57 ± 0.8
1% Na-deoxycholate in 40 mM
Tris/HCl, pH 8.0
22 ± 1.5 12 ± 0.3
Percentage of solubilization of IBs in different solvents was calculated using as
100% the protein concentration obtained dissolving IBs in urea 8 M and
comparing this value with the protein concentration of samples obtained by
treatment with different solvents. Evaluation of protein concentration was
obtained by measuring the absorbance at 280 nm (Abs280).
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Figure 2 Absorption spectra of ferm-flavoHb and flask-flavoHb. Absorption spectra of cold-adapted flavohemoglobin extracted from IBs
produced in fermenter (ferm-flavoHb) and in flask (flask-flavoHb). The spectra were recorded in 0.2% N-lauroyl sarcosine, 40 mM Tris/HCl pH 8.0,
and the proteins concentration was 2 μM.
Parrilli et al. Microbial Cell Factories 2010, 9:19
http://www.microbialcellfactories.com/content/9/1/19
Page 4 of 10To explore the secondary structure of flask-flavoHb
and ferm-flavoHb proteins, circular dichroism mea-
surements were performed. As shown in figure 4, both
proteins display secondary structure, although not
identical since the two recorded CD spectra are clearly
not superimposable. The collected CD data were used
to calculate the percentage of a-helix, b-sheets and
random coil for each protein (by using the software
K2d, accessible through the site http://www.embl-
heidelberg.de/~andrade/k2d[29,30]). As shown in table
2, the two proteins differ significantly in their
secondary structure content, and the ferm-flavoHb
protein is predicted to have a higher content of either
b-sheets or a-helix.
The structural comparison between flask-flavoHb and
ferm-flavoHb proteins was then extended to the study
of fluorescence emission spectra of tryptophan residues
(3 Trp residues are present in the PhflavoHb sequence).
Emission spectra in the range between 310 nm and 500
nm, exciting at 295 nm, were recorded and are pre-
sented in figure 5. Both proteins display an emission
spectrum lmax close to 338 nm, indicating that Trp
Figure 3 Fluorescence spectra of ferm-flavoHb and flask-flavoHb. Fluorescence spectra of cold-adapted flavohemoglobin extracted from IBs
produced in fermenter (ferm-flavoHb) and in flask (flask-flavoHb). The spectra were obtained exciting at 450 nm and recording emission
between 500 nm and 600 nm. The proteins were in 0.2% N-lauroyl sarcosine, 40 mM Tris/HCl pH 8.0, and their concentration was 2 μg/μl.
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Figure 4 CD analysis of ferm-flavoHb and flask-flavoHb. CD analysis of ferm-flavoHb (A) and flask-flavoHb (B). The CD spectra were recorded
in phosphate buffer 40 mM pH 8.0 at 25°C, the proteins concentration was 100 ng/μl.
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Page 5 of 10residues are not solvent exposed. Both protein prepara-
tions were fully denatured by addition of guanidinium
chloride (at a final concentration of 6 M) and the expo-
sure of the tryptophan residues to a more polar environ-
ment was mirrored by the shift of the emission
maximum to 366 nm (data not shown).
Spectra presented in figure 5 differ in the intensity of
lmax signal, where flask-flavoHb protein has a fluores-
cence emission at 338 nm about three times higher than
that of ferm-flavoHb. To investigate if the FAD cofactor,
which is present only in ferm-flavoHb protein, is respon-
sible for the observed quenching of the signal at 338 nm,
tryptophan fluorescence spectra of flask-flavoHb were
recorded in the presence of two molar ratio of exogenous
FAD. As shown in figure 6, the intensity of lmax signal is
not quenched by the addition FAD molecule, neither in
the presence of the higher 1:1 FAD:protein molar ratio.
Influence of different process parameters on inclusion
bodies protein
In order to understand which process parameter is
more relevant in flavohemoglobin production, i.e. if
the observed differences between flask-flavoHb and
ferm-flavoHb depend on the SNP presence, on the
bioreactor geometry, or on oxygen availability, three
different production processs e t u p sw e r ee x p l o r e d .T h e
production of the PhflavoHb was carried out at 20°C
in 7.5 L automatic fermenter, in microaerophilic condi-
tions without SNP, in aerobic condition with and with-
out SNP (always following the previously described
induction conditions). Then, cells coming from the
above production processes were analyzed and flavohe-
moglobin resulted to accumulate in inclusion bodies in
all tested condition. P. haloplanktis TAC125 flavoHb
IBs extracted from the different production processes
were solubilized in presence of 0.2% N-lauroyl sarco-
sine. As shown in Figure 7, the solubilized IBs pro-
duced in fermenter contain almost only the
psychrophilic recombinant protein indicating that the
different protein composition of solubilized IBs of
flask-flavoHb and ferm-flavoHb (Figure 1) was due to
the bioreactor geometry, i.e flask or automatic
Table 2 Percentage of calculated secondary structures of
ferm-flavoHb and flask-flavoHb
Estimation of protein secondary
structure from CD spectra by K2d
ferm-flavoHb flask-flavoHb
a-helix 46% 39%
b-sheets 23% 17%
random coil 31% 44%
Percentage of secondary structures was calculated from CD data spectra by
K2d software (Merelo, Andrade). K2d offers an algorithm for the estimation of
the percentages of protein secondary structure from UV circular dichroism
spectra using a Kohonen neural network
In case of ferm-flavoHb secondary structure prediction, the program has given
a maximum error of 0.080. The maximum error obtained for flask-flavoHb
secondary structure prediction is 0.085. This means that the sum of the errors
in the prediction of the alpha, beta and random percentage values divided by
three is expected to be less then 0.085. In both cases the error values are
below the threshold maximal error 0.227. Maximal errors above this value
indicate that the result given by the network prediction is not reliable.
Figure 5 Tryptophan fluorescence spectra of ferm-flavoHb and flask-flavoHb. Fluorescence spectra of ferm flavoHb (A) and flask-flavoHb
(B) obtained recording an emission spectra between 200 nm and 500 nm exciting at 295 nm. Fluorescence spectra were recorded in 0.2% N
lauroyl sarcosine, 40 mM Tris/HCl pH 8.0, protein concentration was 2 μg/μl.
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Page 6 of 10fermenter. The analyses aimed to investigate the pre-
sence of the heme and FAD (data not shown) demon-
strated that proteins obtained in microaerophilic
conditions without SNP and in aerobic condition with
and without SNP lack of both cofactors.
Discussion
Several recent reports have shown that IBs could con-
tain proteins that posses a native-like secondary struc-
ture and an enzymatic activity [3,5-7]. Moreover, it has
been reported that IBs containing a high proportion of
correctly folded protein can be easily solubilized under
non-denaturing conditions [9]
In this paper we report a case in which using different
process designs, we always obtained the complete accu-
mulation of the recombinant proteins in IBs, from
which the products were easily solubilized under non-
denaturing conditions. Although their common attitude
to get solubilized, recombinant proteins deriving from
the different production processes differ in presence of
cofactors and in their secondary and tertiary structure.
In detail, we produced the flavohemoglobin from the
Antarctic Gram-negative bacterium P. haloplanktis
TAC125 [22] in E. coli cells in fermenter in the presence
of a nitrosating compound (the SNP) and in microaero-
biosis. In parallel, PhflavoHb was produced in E. coli
recombinant cells in standard conditions, i.e. grown in
shake flasks by an aerobic production scheme and in
absence of SNP. Both processes, carried out at 20°C,
resulted in the total accumulation of the recombinant
protein in cytoplasmic inclusion bodies. The treatment
of ferm-flavoHb IBs and flask-flavoHb IBs with a
N-lauroyl sarcosine solution highlighted unexpected dif-
ferences in i) the solubilization yield, and ii) the compo-
sition of the solubilized matter. This evidence prompted
us to carry out a structural comparison of the two
recombinant PhflavoHbs, in order to assess if the pro-
duction setup could influence the main structural fea-
tures of IBs proteins. Data reported in the present paper
demonstrate that the two proteins differ significantly,
mainly in the presence of FAD and heme cofactors.
Indeed, when subjected to suitable spectroscopic ana-
lyses, proofs of the presence of heme and FAD were col-
lected only in the case of ferm-flavoHb. Furthermore,
CD spectra demonstrate that both proteins possess a
secondary structure, but the ferm-flavoHb content of
alpha-helix and beta-sheets is higher than that observed
in the protein produced in flask.
Taking advantage from the presence of three tryptophan
residues along the PhflavoHb protein sequence, fluores-
cence emission spectra of tryptophan residues were
recorded. Both spectra are characterized by a lmax emis-
sion signal around 338 nm, a result indicative that the Trp
residues are not exposed to the solvent. Indeed, in these
experimental conditions, unfolded proteins usually present
as h i f to flmaxtowards 350 nm. As expected, when the pro-
teins were chemically denatured by guanidinium chloride,
a shift of the lmax emission signal was observed (new max-
imum at 366 nm, data not shown). These data are highly
suggestive that both protein sd i s p l a ya3 Ds t r u c t u r e ,
although likely not identical. In fact, fluorescence intensity
at lmax of flask-flavoHb is about three times higher than
that of the protein produced in fermenter. This different
spectroscopic behaviour is not justified by the likely
quenching effect of FAD cofactor associated only to the
ferm-flavoHb. Therefore, the observed difference in inten-
sity of lmax signal could be due to some amino acids resi-
dues close to tryptophan residues that work as
fluorescence quencher in ferm-flavoHb. These results are
suggestive of a different chemical surrounding around the
tryptophan residues in flask-flavoHb and ferm-flavoHb
proteins, thus supporting the conclusion that the two pro-
teins differ in 3D structure too.
Furthermore, a systematic approach was applied to
understand which process parameter was crucial for
obtaining a protein endowed with FAD and heme cofac-
tors. It turned out that the synergic effect of microareophi-
l i cg r o w t hc o n d i t i o n sa n dt h ep r e s e n c eo fS N Pw a s
essential. This experimental setup likely mimics the phy-
siologic conditions in which flavoHb activity is required.
The occurrence of a suitable physical-chemical environ-
ment and/or the induction of specific protein chaperones
could justify the unique cofactors incorporation observed.
Figure 6 Tryptophan fluorescence spectra of flask-flavoHb in
presence of FAD. Tryptophan fluorescence spectra of flask-flavoHb
in presence of FAD cofactor. FAD was added to flask-flavoHb
protein at molar ratio of 1:10 and 1:1. Fluorescence spectra were
recorded in 0.2% N-lauroyl sarcosine, 40 mM Tris/HCl pH 8.0,
proteins concentration was 2 μg/μl.
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native PhflavoHb, a final assessment on the quality of
the recombinant proteins produced in this work cannot
be formulated. However, the presence of FAD and heme
cofactors, together with the collected indirect evidences
of a different secondary and, eventually, tertiary struc-
tures, looks very promising of a better quality of flavoHb
obtained in the presence of a nitrosating compound and
in microaerobiosis.
Conclusions
The present paper describes the recombinant produc-
tion of a flavohemoglobin, a multidomain protein
requiring FAD and heme cofactors for its activity. Two
significantly different production process designs were
explored, both resulting in the full product accumula-
tion in IBs. Data reported here demonstrate that other
process parameters, besides growth temperature, influ-
ence the quality of a recombinant product even if it
accumulates in IBs. To the best of our knowledge, this
is the first reported example in which the quality of pro-
tein solubilized from inclusion bodies has been corre-
lated to the production process design.
Methods
Bacterial strains, plasmid and culture condition
The E. coli BL21(DE3) (Novagen) strain was routinely
used for cloning and expressing recombinant gene. Cells
were grown in Luria-Bertani (LB) medium at 20°C.
When required, ampicillin (Sigma) was added at 100 μg/
ml. Plasmid pET-22b (Novagen) was utilized for cloning
and expression. Restriction and modifying enzymes were
obtained from Promega. The oligonucleotides were cus-
tom synthesized from PRIMM.
Cloning of the PSHAa2880gene
The primer pairs for the PSHAa2880 gene (Oligo 2880
fw 5’ TTCATATGTTATCTGATAAAACTATTGAAA
3’, Oligo 2880 rv 5’ AAGTCGACTTATAGATCTT-
GATGCGG 3’) were designed on the basis of the P.
haloplanktis TAC125-genome sequence [31]. Sequences
corresponding to the NdeIs i t ea n daSalIs i t ew e r e
introduced in the forward and reverse primers, respec-
tively. The amplifications were performed in a mixture
containing 80 ng of P. haloplanktis TAC125-genomic
DNA as template, 50 pmol of each oligonucleotide pri-
mer, 1.8 mM MgCl2, 50 mM KCl, 20 mM Tris-HCl pH
8.3, 0.1% gelatine, 200 μM dNTP in a final volume of 50
μl. The mixtures were incubated at 95°C for 10 min,
then 1.25 units of Taq DNA polymerase were added.
Twenty cycles of amplification (consisting of 1 min at
95°C, 1.5 min at 60°C and 1 min plus 5 sec/cycle at 72°
C) were carried out and followed by a cycle in which
the extension reaction at 72°C was prolonged for 15
min in order to complete DNA synthesis. The amplified
fragment was cloned and its nucleotide sequence
checked to rule out the occurrence of any mutation dur-
ing synthesis. The NdeI-SalI-digested fragment of the
PSHAa2880 gene was then subcloned into the corre-
sponding sites of the expression vector pET-22b,
Figure 7 FlavoHb inclusion bodies produced in automatic fermenter in different conditions.S D S - P A G Eo fPhflavoHb IBs extracted from
culture obtained in microaerophilic conditions without SNP (1), in aerobic condition with (2) and without SNP (3). IBs were-suspended in 0.2%
N-lauroyl sarcosine 40 mM Tris/HCl, pH 8.0.
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vector was used to transform E. coli BL21(DE3) cells,
that were used for the following production processes.
All DNA manipulation were performed as previously
described [32]
Shake Flask Culture
For the over-expression of cold-adapted flavoHb in flask,
as i n g l ec o l o n yo fr e c o m b i n a n tE. coli BL21(DE3)
(pET22b-2880) was inoculated in LB medium supple-
mented with 4 g/L glucose and ampicillin (100 μg/ml)
and allowed to grow at 20°C, in the rotary shaker, until
absorbance at 600 nm reached ~0.6 OD. The culture
was then induced with 1 mM isopropyl-b-D-thiogalacto-
pyranoside and further incubated for another 16-18 h at
20°C in the presence of 50 μM of D-aminolevulinic acid,
3 μMF e C l 3, 100 μM riboflavin. After production, the
cell culture was aliquoted, centrifuged, and the superna-
tant was discarded. The bacterial pellet was stored for
further analysis.
Laboratory Fermentation
A proper preinoculum of overnight grown recombinant
E. coli BL21(DE3) (pET22b-2880) was diluted in 4.5 L of
LB medium supplemented with 4 g/L glucose and ampi-
cillin (100 μg/ml) in a 7.5-L Techfors S (Infors, HT
Switzerland) automatic fermenter. Cells were grown
aerobically at 20°C till the culture density reached the
value of 0.6 OD at 600 nm. Induction was then per-
formed by 1 mM IPTG, in the presence of 50 μMm M
D-aminolevulinic acid, 3 μMF e C l 3, 100 μMr i b o f l a v i n
and 0.4 mM sodium nitroprusside (SNP). Then, air sup-
ply was stopped during the next 16-18 hr of fermenta-
tion keeping a microaerophilic conditions (dissolved
oxygen tension always below 5% of saturation).
In case of production of the PhflavoHb in aerobic condi-
tion with and without SNP the preinoculum of overnight
grown recombinant E. coli BL21(DE3) (pET22b-2880)w a s
diluted in 2.5 L of medium and dissolved oxygen tension
was maintained always above 30% of saturation.
After production, the cell culture was collected, centri-
fuged, and the supernatant was discarded. The bacterial
pellet was stored for further analysis.
Protein inclusion bodies extraction
Biomass was harvested at the end of the production
process by centrifugation, and the wet bacterial pellet
was re-suspended in 10 mM Tris/HCl, pH 8.0. Samples
were kept on ice and disrupted by sonication using an
Branson sonicator (Model B-15), using a program con-
sisting of 20 cycles (30” on, 60” off, intensity 4.5). After
disruption of the cells, samples were centrifuged at 5000
rpm for 30 min at a constant temperature of 4°C. The
supernatant was discarded, and the inclusion bodies
fraction was washed twice with chilled water, divided in
several aliquots and incubated overnight for the solubili-
zation at 4°C in 40 mM Tris/HCl, pH 8.0 buffer con-
taining alternatively:
￿ 5% n-propanol;
￿ 0.5% Triton X-100;
￿ 5% DMSO;
￿ 1% Na-deoxycholate;
￿ 0.2% N-lauroyl sarcosine.
As negative control the insoluble matter was treated
with water. After the incubation, the suspensions were
centrifuged at 4400 × g for 15 minutes at 4°C. The
supernatants were analyzed by SDS-PAGE.
Protein concentration measurements
The Bradford method [33] was applied to determine
protein concentration. In case of protein solubilized
from IBs with different solvents a qualitative measure of
protein content was determined by measuring the
amount of light absorbed at 280 nm (Abs280).
Spectroscopic Measurements
UV-Vis absorption spectra were recorded in UNIKON
930 spectrophotometer. Fluorescence measurements
were carried out in a PERKIN ELMER LS 50B fluoros-
pectrometer. Circular dichroism (CD) spectra were
obtained in a Jasco spectropolarimeter (model J-715)
equipped with a thermostatically controlled cell holder.
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